Patents by Inventor Jörg Plessl

Jörg Plessl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170296575
    Abstract: The present invention concerns a solid formulation for oral administration as a solid comprising polyethylene glycol and a further solid such as mannitol. The formulation may be used to prevent gastrointestinal disorders such as constipation in healthy subjects. In some embodiments, the solid formulation is chewable or suckable.
    Type: Application
    Filed: June 28, 2017
    Publication date: October 19, 2017
    Inventors: Peter Stein, Leighton Jones, Samuel Smith, Ian Cox, Jörg Plessl
  • Publication number: 20160228467
    Abstract: The present invention relates to methods for and of treating, ameliorating or preventing colorectal cancer (CRC) in humans using polyethylene glycol (PEG) or a PEG block-copolymer such as Pluronic® F68. Compositions for use in treating, ameliorating and/or preventing CRC comprising PEG are also disclosed. Such compositions may be used in the methods of the invention.
    Type: Application
    Filed: April 21, 2016
    Publication date: August 11, 2016
    Inventors: Peter Stein, Ian Cox, Samuel Smith, Leighton Jones, Jörg Plessl, Corinne De Vries, Rachel Charlton
  • Publication number: 20130225692
    Abstract: The present invention concerns a solid formulation for oral administration as a solid comprising polyethylene glycol and a further solid such as mannitol. The formulation may be used to prevent gastrointestinal disorders such as constipation in healthy subjects. In some embodiments, the solid formulation is chewable or suckable.
    Type: Application
    Filed: November 4, 2011
    Publication date: August 29, 2013
    Inventors: Peter Stein, Leighton Jones, Samuel Smith, Ian Cox, Jörg Plessl
  • Publication number: 20130216493
    Abstract: The present invention relates to methods for and of treating, ameliorating or preventing colorectal cancer (CRC) in humans using polyethylene glycol (PEG) or a PEG block-copolymer such as Pluronic® F68. Compositions for use in treating, ameliorating and/or preventing CRC comprising PEG are also disclosed. Such compositions may be used in the methods of the invention.
    Type: Application
    Filed: November 4, 2011
    Publication date: August 22, 2013
    Applicant: Norgine BV
    Inventors: Peter Stein, Leighton Jones, Samuel Smith, Ian Cox, Jörg Plessl, Corinne De Vries, Rachel Charlton